News

PathAI has recently launched updated versions of these tools on the AISight Translational Research platform 1. IBD Explore v2 ...
Cetera, the premier financial advisor Wealth Hub, announced today that Cetera's employee-based RIA, The Retirement Planning Group (TRPG), successfully closed three practice acquisitions during the ...
Microba Life Sciences Limited (ASX: MAP) (“Microba”) a precision microbiome company, today announces two significant de ...
Waymo and Toyota signed a deal to explore the development of an autonomous vehicle platform and personally owned vehicles.
Heading into Square-parent Block's first-quarter earnings report, Wall Street expectations are running low, with some analysts expecting a guidance cut. Bulls hold out hope that Chief Executive Jack ...
The risk for food allergy, asthma and allergic rhinitis was elevated among children who received antibiotics in early childhood, and risk was greater with five-plus courses, according to data ...
This neural encoding of cytokines is disrupted during inflammation associated with a colitis model. Inflammatory bowel disease (IBD) is an immune-mediated disease with substantial burden worldwide.
CEO Ritik Malhotra is leveraging Savvy Wealth's Fidelity partnership in offers to Commonwealth advisors, alongside ...
AbbVie Inc.'s Q1 earnings highlight an 8.4% revenue boost, driven by Skyrizi & Rinvoq. Click for ABBV's market expansion, ...
Scientists at Quris Technologies have uncovered evidence that some drugs become significantly more harmful to brain ...
Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead ...
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that co-founders Andrew Barnell, MBA, and Erica Barnell ...